Index of reports
> Disability (62)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin disability. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 62 Next >>
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Switzerland on 2012-08-22
Patient: 65 year old female
Reactions: Vomiting, Diarrhoea, Anaemia, General Physical Health Deterioration
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Avastin
Indication: Adenocarcinoma
Start date: 2011-12-30
Cisplatin
Indication: Adenocarcinoma
Start date: 2011-12-30
Carboplatin
Indication: Adenocarcinoma
Start date: 2011-02-14
Pemetrexed Disodium
Indication: Adenocarcinoma
Start date: 2011-12-30
Other drugs received by patient: Crestor; Potassium Chloride; Norfloxacin; Dolpasse
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Switzerland on 2012-08-21
Patient: 65 year old female
Reactions: Vomiting, Diarrhoea, Anaemia, General Physical Health Deterioration, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Pemetrexed Disodium
Dosage: date of last dose prior to sae: 20/jan/2012
Indication: Adenocarcinoma
Start date: 2011-12-30
Cisplatin
Dosage: date of last dose prior to sae: 20/jan/2012
Indication: Adenocarcinoma
Start date: 2011-12-30
Avastin
Dosage: date of last dose prior to sae: 20/jan/2012
Indication: Adenocarcinoma
Start date: 2011-12-30
Carboplatin
Indication: Adenocarcinoma
Start date: 2011-02-14
Other drugs received by patient: Crestor; Dolpasse; Potassium Chloride; Norfloxacin
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-07-27
Patient: male, weighing 48.0 kg (105.6 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia Aspiration, Vomiting, Pulmonary Embolism, Leukoencephalopathy, Pyrexia, Neutrophil Count Decreased, Decreased Appetite
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Alimta
Indication: Lung Adenocarcinoma Recurrent
Start date: 2012-03-13
End date: 2012-03-13
Methylprednisolone Sodium Succinate
Dosage: dosage is uncertain.
Indication: Leukoencephalopathy
Start date: 2012-04-26
End date: 2012-01-01
Avastin
Indication: Lung Neoplasm Malignant
Start date: 2012-03-13
End date: 2012-03-13
Carboplatin
Dosage: dosage: 5 auc a day
Indication: Lung Adenocarcinoma Recurrent
Start date: 2012-03-13
End date: 2012-03-13
Other drugs received by patient: Tannalbin; Panvitan; Flivas; Neuer; Medicon; Urso 250; Eviprostat
Possible Carboplatin side effects in male
Reported by a pharmacist from United States on 2012-07-25
Patient: male, weighing 106.3 kg (233.9 pounds)
Reactions: Chest Pain
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: 180-150mg 4 cycles iv drip
Indication: Head and Neck Cancer
Start date: 2012-03-19
End date: 2012-04-09
Dexamethasone Sodium Phosphate
Dosage: 20mg once w/ chemo iv drip
Indication: Vomiting
Start date: 2012-03-19
End date: 2012-04-25
Other drugs received by patient: Metorpolol Tartrate 300mg; Diphenhydramine 50mg; Rosuvastatin; Isosorbide Dinitrate 90mg; Ondansetron 8MG IV; Cetuximab 580mg; Ranitidine 450mg; Acetaminophen; Lisinopril; Amlodipine Besylate; Levothyroxine NA 0.088mg
Possible Carboplatin side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Febrile Neutropenia, Radiation Mucositis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df auc =5, dose redused to auc 3.
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Gemcitabine Hydrochloride
Dosage: last dose on:11jun12 dose redused to:500mg/m2
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Ramucirumab
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Other drugs received by patient: Warfarin Sodium; Levaquin; Roxanol; Neupogen; Zometa; Methadone HCL; Promethazine; Prilosec; Platelets; Ondansetron
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-07-17
Patient: male, weighing 64.7 kg (142.3 pounds)
Reactions: Febrile Neutropenia, Radiation Mucositis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Gemcitabine Hydrochloride
Dosage: 500 mg/m2, other
Gemcitabine Hydrochloride
Dosage: 1000 mg/m2, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-11
Ramucirumab (1121b) (Ly3009806)
Dosage: 10 mg/kg, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Carboplatin
Dosage: unk, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-04
Carboplatin
Dosage: 3 df, other
Other drugs received by patient: Hydrocodone; Roxanol; Ondansetron; Promethazine; Zometa; Levaquin; Methadon HCL TAB; Prilosec; Warfarin Sodium; Neupogen; Platelets; Promethazine
Possible Carboplatin side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17
Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Oropharyngeal Pain, Neutropenia, Radiation Mucositis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ramucirumab
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Gemcitabine Hydrochloride
Dosage: last dose on:11jun12 dose redused to:500mg/m2
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Carboplatin
Dosage: 1df auc =5, dose redused to auc 3.
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Other drugs received by patient: Prilosec; Ondansetron; Neupogen; Methadone HCL; Levaquin; Roxanol; Zometa; Promethazine; Warfarin Sodium; Platelets
Possible Carboplatin side effects in 4 month old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10
Patient: 4 month old female
Reactions: Wrong Technique in Drug Usage Process, Deafness Bilateral, Incorrect Drug Administration Duration, Drug Level Increased, Drug Dispensing Error
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-07-05
Patient: male, weighing 64.7 kg (142.3 pounds)
Reactions: Radiation Mucositis, Neutropenia, Oropharyngeal Pain
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: unk, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-04
Gemcitabine Hydrochloride
Dosage: 500 mg/m2, other
Ramucirumab (1121b) (Ly3009806)
Dosage: 10 mg/kg, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Gemcitabine Hydrochloride
Dosage: 1000 mg/m2, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-11
Carboplatin
Dosage: 3 df, other
Other drugs received by patient: Ondansetron; Levaquin; Prilosec; Roxanol; Promethazine; Zometa; Hydrocodone Bitartrate; Warfarin Sodium; Methadon HCL TAB; Platelets; Neupogen; Promethazine
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-06-29
Patient: male, weighing 48.0 kg (105.6 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia Aspiration, Vomiting, Pulmonary Embolism, Pyrexia, Leukoencephalopathy, Neutrophil Count Decreased, Decreased Appetite
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Alimta
Indication: Lung Adenocarcinoma Recurrent
Start date: 2012-03-13
End date: 2012-03-13
Avastin
Indication: Lung Neoplasm Malignant
Start date: 2012-03-13
End date: 2012-03-13
Carboplatin
Dosage: dosage: 5 auc a day
Indication: Lung Adenocarcinoma Recurrent
Start date: 2012-03-13
End date: 2012-03-13
Other drugs received by patient: Eviprostat; Flivastatin Sodium; Tannalbin; Neuer; Medicon; Panvitan; Excelase (Unk Ingredients); Urso 250
Possible Carboplatin side effects in female
Reported by a physician from Germany on 2012-06-13
Patient: female, weighing 95.0 kg (209.0 pounds)
Reactions: Pulmonary Embolism
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Bevacizumab
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-06-01
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2012-02-28
Carboplatin
Indication: Breast Cancer
Start date: 2012-02-28
Taxol
Indication: Breast Cancer
Start date: 2012-02-28
Possible Carboplatin side effects in 52 year old male
Reported by a physician from Austria on 2012-06-04
Patient: 52 year old male, weighing 108.0 kg (237.6 pounds)
Reactions: Dyspnoea, Cardiac Failure, Neoplasm Malignant, Radiation Pneumonitis, Cardiomyopathy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-07-13
Avastin
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-09-21
Alimta
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-07-13
Possible Carboplatin side effects in 52 year old male
Reported by a individual with unspecified qualification from Denmark on 2012-06-01
Patient: 52 year old male
Reactions: Dyspnoea, Neoplasm Progression, Radiation Pneumonitis, Metastatic Bronchial Carcinoma, Cardiomyopathy, Cardiac Failure Congestive
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: iv
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-07-13
Alimta
Dosage: 500 mg/m**2
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-07-13
Avastin
Dosage: 7.5 mg/kg
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-09-21
Possible Carboplatin side effects in female
Reported by a physician from France on 2012-05-31
Patient: female
Reactions: Visual Acuity Reduced Transiently
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 30 milligram/sq. meter
Indication: Ovarian Cancer
Start date: 2011-10-19
Carboplatin
Dosage: 475 milligram
Indication: Ovarian Cancer
Start date: 2011-10-19
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Ovarian Cancer
Start date: 2011-10-20
End date: 2011-11-03
Other drugs received by patient: Lamotrigine; Lovenox; Oxazepam
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-05-24
Patient: female
Reactions: Metastases To Thorax, Metastases To Peritoneum
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Ovarian Cancer Recurrent
Start date: 2000-01-01
End date: 2009-01-01
Carboplatin
Indication: Ovarian Cancer Recurrent
Possible Carboplatin side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-23
Patient: 68 year old female, weighing 63.0 kg (138.6 pounds)
Reactions: Diplopia, Iiird Nerve Paralysis, Metastases To Meninges, Iiird Nerve Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Indication: Lung Cancer Metastatic
Navelbine
Dosage: 25 mg/m2 iv
Indication: Lung Cancer Metastatic
Start date: 2012-03-19
End date: 2012-04-02
Possible Carboplatin side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from Austria on 2012-05-22
Patient: 52 year old male, weighing 108.0 kg (237.6 pounds)
Reactions: Dyspnoea, Cardiac Failure, Neoplasm Progression, Radiation Pneumonitis, Cardiomyopathy, Left Ventricular Failure
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: unk
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-06-01
Alimta
Dosage: 500 mg/m2, unk
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-07-13
Alimta
Dosage: unk
Start date: 2012-04-30
Avastin
Dosage: 7.5 mg/kg, unk
Indication: Chemotherapy
Start date: 2011-03-24
End date: 2011-07-13
Avastin
End date: 2011-09-21
Carboplatin
Dosage: unk
Indication: Chemotherapy
Start date: 2011-06-01
End date: 2011-07-13
Possible Carboplatin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-17
Patient: 48 year old female, weighing 77.0 kg (169.4 pounds)
Reactions: Optic Atrophy, Retinal Haemorrhage, Visual Impairment, Visual Acuity Reduced, Vision Blurred, Papilloedema
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Dexamethasone; Omeprazole; Paclitaxel; Acetaminophen; Codeine Phosphate (Codeine Phosphate); Ranitidine Hydrochloride; Ferrous Sulfate TAB; Ondansetron; Domperidone (Domperidone)
Possible Carboplatin side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-15
Patient: 50 year old female
Reactions: Telangiectasia, Oedema Peripheral, Finger Amputation, Gangrene, Peripheral Ischaemia, RED Blood Cell Sedimentation Rate Increased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gemcitabine
Dosage: ; iv
Indication: Neoplasm Malignant
Carboplatin
Dosage: ; iv
Indication: Neoplasm Malignant
Other drugs received by patient: Grape Seed; Thyroid TAB; Multi-Vitamin
Possible Carboplatin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14
Patient: 48 year old female, weighing 34.9 kg (76.8 pounds)
Reactions: Optic Atrophy, Retinal Haemorrhage, Drug Hypersensitivity, Visual Acuity Reduced, Vision Blurred, Papilloedema
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Ferrous Sulfate TAB; (Domperidone); Omeprazole; Ondansetron; Dexamethasone; Ranitidine; Acetaminophen; (Codeine Phosphate); Paclitaxel
Possible Carboplatin side effects in 48 year old female
Reported by a physician from United Kingdom on 2012-05-13
Patient: 48 year old female, weighing 77.0 kg (169.4 pounds)
Reactions: Optic Atrophy, Retinal Haemorrhage, Visual Impairment, Visual Acuity Reduced, Vision Blurred, Papilloedema
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Domperidone; Dexamethasone; Codeine Phosphate; Omeprazole; Paclitaxel; Acetaminophen; Ondansetron; Ranitidine; Ferrous Sulfate TAB
Possible Carboplatin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08
Patient: 48 year old female, weighing 77.0 kg (169.4 pounds)
Reactions: Optic Atrophy, Retinal Haemorrhage, Visual Impairment, Visual Acuity Reduced, Vision Blurred, Optic Neuritis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Dexamethasone; Ranitidine; Omeprazole; Acetaminophen; Domperidone; Ferrous Sulfate TAB; Codeine Phosphate; Ondansetron; Paclitaxel
Possible Carboplatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-04-26
Patient: male
Reactions: Dysarthria, Visual Impairment, Hypothyroidism, Ataxia, Deafness, Coordination Abnormal, Cognitive Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Temozolomide
Dosage: not reported
(Therapeutic Radiopharmaceuticals)
Dosage: 35 gy, unknown, other
Vincristine Sulfate
Dosage: not reported
Etoposide
Dosage: not reported
Cyclophosphamide
Dosage: not reported
Carboplatin
Dosage: 700 mg/m 2 milligram(s)/sq. meter
Cisplatin
Dosage: 80 mg/m 2 milligram(s)/sq. meter
Depocyt
Dosage: 50 mg milligram(s), intrathecal
(Lomustine)
Dosage: not reported
Possible Carboplatin side effects in 60 year old male
Reported by a consumer/non-health professional from Switzerland on 2012-04-24
Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Osteonecrosis, Aneurysm
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Zometa
Dosage: intrp and reintiated,last dose on 09feb12 again suspended
Indication: Neoplasm Malignant
Start date: 2009-06-16
End date: 2012-02-09
Herceptin
Indication: Breast Cancer
Start date: 2011-11-01
Avastin
Indication: Breast Cancer
Start date: 2010-03-09
End date: 2011-02-14
Carboplatin
Indication: Breast Cancer
Start date: 2011-11-01
Taxotere
Indication: Breast Cancer
Start date: 2011-11-01
Taxol
Indication: Breast Cancer
Start date: 2010-03-09
End date: 2011-02-14
Other drugs received by patient: Neulasta
Possible Carboplatin side effects in 60 year old male
Reported by a physician from Switzerland on 2012-04-24
Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Osteonecrosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Start date: 2011-11-01
Zometa
Indication: Bone Neoplasm
Start date: 2009-06-16
End date: 2012-02-09
Avastin
Indication: Breast Cancer
Start date: 2010-03-09
End date: 2010-03-09
Carboplatin
Indication: Breast Cancer
Start date: 2011-11-01
Taxotere
Indication: Breast Cancer
Start date: 2011-11-01
Taxol
Indication: Breast Cancer
Start date: 2010-03-09
End date: 2011-02-14
Other drugs received by patient: Neulasta
Possible Carboplatin side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-04-20
Patient: 60 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Osteonecrosis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Carboplatin
Start date: 2011-11-01
Taxol
Start date: 2010-03-09
End date: 2011-02-14
Zometa
Indication: Bone Neoplasm Malignant
Start date: 2009-06-16
End date: 2011-01-01
Taxotere
Start date: 2011-11-01
Zometa
Start date: 2011-01-01
End date: 2012-02-09
Avastin
Dosage: frequency reported as one per 2 week
Start date: 2010-03-09
End date: 2011-02-14
Trastuzumab
Start date: 2011-11-01
Other drugs received by patient: Neulasta
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Switzerland on 2012-04-11
Patient: 65 year old female
Reactions: Vomiting, Diarrhoea, Anaemia, General Physical Health Deterioration
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cisplatin
Indication: Adenocarcinoma
Start date: 2011-12-30
Avastin
Indication: Adenocarcinoma
Start date: 2011-12-30
Carboplatin
Indication: Adenocarcinoma
Start date: 2011-02-14
Pemetrexed Disodium
Indication: Adenocarcinoma
Start date: 2011-12-30
Other drugs received by patient: Crestor; Dolpasse; Norfloxacin; Potassium Chloride
Possible Carboplatin side effects in female
Reported by a physician from France on 2012-04-05
Patient: female
Reactions: Blindness Unilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Ovarian Cancer
Start date: 2011-10-20
End date: 2011-11-03
Doxorubicin Hydrochloride
Dosage: 30 milligram/sq. meter
Indication: Ovarian Cancer
Start date: 2011-10-19
Carboplatin
Dosage: 475 milligram
Indication: Ovarian Cancer
Start date: 2011-10-19
Other drugs received by patient: Lovenox; Lamotrgine; Oxazepam
Possible Carboplatin side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-05
Patient: 3 year old
Reactions: Respiratory Failure, Drug Interaction
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient possibly interacting with the suspect drug: Etoposide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Cyclophosphamide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Thiotepa
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Possible Carboplatin side effects in 3 year old
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-03-29
Patient: 3 year old
Reactions: Respiratory Failure, Pneumomediastinum, Acute Respiratory Distress Syndrome, Pneumothorax
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Etoposide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Thiotepa
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Cyclophosphamide
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Carboplatin
Dosage: hit 2000 met-bis4 protocol
Indication: Medulloblastoma
Page 1 Next >>
|